Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
John Bencich is CHIEF FINANCIAL OFFICER at Aeon Biopharma. OQRO lists 1 transaction filed with the SEC under this name, the latest on Apr 3, 2026, each linked to the official Form 4.
CHIEF FINANCIAL OFFICER
Disclosures on record
1
Companies involved
1
John Bencich bought shares on the open market in 2021, 2022, 2023 and 2024, and has not bought since 2024. Sales in 2 of the 12 years since 2015.
John Bencich reported 4 open-market purchases and 3 sales since 2015; purchases in 4 different years, most recently 2024.
| Year | Bought | Sold |
|---|---|---|
| 2024 | $46K1×1 trade | — |
| 2023 | $28K1×1 trade | — |
| 2022 | —1×1 trade | — |
| 2021 | $42K1×1 trade | — |
| 2016 | — | $1.5K2×2 trades |
| 2015 | — | $3.9K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Aeon BiopharmaAEON
Apr 2, 2026755Kdisclosed Apr 3
DetailsOfficial recordAs of the latest filing on , John Bencich reported holding 754,717 shares of Aeon Biopharma (AEON), worth about $115K at the last close of $0 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Aeon Biopharma AEON | 754,717 | 755K direct | $0 | $115K | Apr 2, 2026 |
Is this John Bencich’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Apr 2, 2026, John Bencich reported holding 754,717 shares of Aeon Biopharma (AEON). At the last close of $0 on Nov 13, 2026, that is about $115K. This is the stake disclosed in filings, not a net worth.
John Bencich bought shares on the open market in 2021, 2022, 2023 and 2024, and has not bought since 2024. Sales in 2 of the 12 years since 2015.
In SEC filings since 2015: the latest open-market purchase is from 2024; the latest open-market sale is from 2016.
Achieve Life Sciences (ACHV), from 2015 to 2024: 4 purchases and 3 sales.
John Bencich reported 4 open-market purchases and 3 sales here, 2015 to 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
